|
Volumn 19, Issue 31, 2001, Pages 4536-4543
|
First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease
|
Author keywords
Field evaluation; Myxoma RHDV; Transmissible vaccine
|
Indexed keywords
6918VP60 T2;
CAPSID PROTEIN;
RECOMBINANT DNA;
UNCLASSIFIED DRUG;
VIRUS VACCINE;
ANTIBODY RESPONSE;
ARTICLE;
BLEEDING DISORDER;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
IMMUNIZATION;
INFECTION PREVENTION;
INOCULATION;
MYXOMA VIRUS;
MYXOMATOSIS;
NONHUMAN;
PRIORITY JOURNAL;
RABBIT;
SEROCONVERSION;
VIRUS DETECTION;
VIRUS INFECTION;
VIRUS RECOMBINANT;
VIRUS TRANSMISSION;
ANIMALS;
ANIMALS, WILD;
CALICIVIRIDAE INFECTIONS;
CELL LINE;
DISEASE TRANSMISSION, HORIZONTAL;
HEMORRHAGIC DISEASE VIRUS, RABBIT;
MYXOMA VIRUS;
MYXOMATOSIS, INFECTIOUS;
RABBITS;
VACCINATION;
VACCINES, COMBINED;
VACCINES, SYNTHETIC;
VIRAL VACCINES;
|
EID: 0035859966
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(01)00184-0 Document Type: Article |
Times cited : (43)
|
References (27)
|